ChemistryCommunications Chemistry
Asymmetric rotaxanes as dual-modality supramolecular imaging agents for targeting cancer biomarkers
F. D'orchymont and J. P. Holland
Discover the groundbreaking research by Faustine d'Orchymont and Jason P. Holland, exploring the innovative synthesis of bimodal and mechanically interlocked rotaxane-based imaging agents aimed at targeting prostate cancer biomarkers. This study showcases the development of a dual-modality imaging agent that can revolutionize cancer diagnostics.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment
L. Zhang, B. Zhai, et al.
Psychology
Urinary exosomal microRNAs as predictive biomarkers for persistent psychotic-like experiences
Y. Tomita, K. Suzuki, et al.
Medicine and Health
Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
G. C, C. M, et al.
Medicine and Health
CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics
L. Hao, R. T. Zhao, et al.
